This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Wyeth. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Mark Antony Ashwell: Innovator in Pharmaceutical Chemistry
Introduction
Mark Antony Ashwell is a notable inventor based in Carlisle, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that address various inflammatory diseases. His expertise and dedication to research have led to the development of a patent that holds promise for treating serious health conditions.
Latest Patents
Mark Antony Ashwell holds a patent for "Substituted dihydrophenanthridinesulfonamides." This invention provides a compound of formulae (I) or (II) having the structure or a pharmaceutically acceptable salt thereof, which are useful for the treatment of the inflammatory component of diseases. The patent is particularly beneficial in treating atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, type II diabetes, and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. He has 1 patent to his name.
Career Highlights
Throughout his career, Ashwell has worked with prominent companies in the pharmaceutical industry, including Wyeth and Arqule, Inc. His experience in these organizations has allowed him to collaborate with other talented professionals and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Albert John Molinari and Brian Hugh Ridgway. Their collective efforts have further advanced the field of pharmaceutical innovations.
Conclusion
Mark Antony Ashwell's contributions to pharmaceutical chemistry through his patent and collaborations highlight his commitment to improving healthcare solutions. His work continues to inspire future innovations in the treatment of inflammatory diseases.